Stem definition | Drug id | CAS RN |
---|---|---|
quinoline derivatives | 1457 | 83-73-8 |
Dose | Unit | Route |
---|---|---|
0.20 | g | V |
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | G01AC01 | GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Quinoline derivatives |
MeSH PA | D000563 | Amebicides |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D000977 | Antiparasitic Agents |
MeSH PA | D000981 | Antiprotozoal Agents |
CHEBI has role | CHEBI:33282 | bactericides |
CHEBI has role | CHEBI:35820 | antiprotozoal drugs |
CHEBI has role | CHEBI:48218 | antiseptics |
CHEBI has role | CHEBI:171664 | antiamoebic drugs |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Amebic infection | indication | 111910009 | DOID:9181 |
Atopic dermatitis | off-label use | 24079001 | DOID:3310 |
Contact dermatitis | off-label use | 40275004 | DOID:2773 |
Lichen simplex chronicus | off-label use | 53891004 | |
Pruritus ani | off-label use | 90446007 | |
Pruritus of genital organs | off-label use | 267802000 | |
Eruption of skin | off-label use | 271807003 | DOID:0050486 |
Optic neuritis | contraindication | 66760008 | DOID:1210 |
Disease of liver | contraindication | 235856003 | DOID:409 |
Telangiectasia disorder | contraindication | 247479008 | |
Peripheral nerve disease | contraindication | 302226006 | |
Adrenal cortical hypofunction | contraindication | 386584007 | DOID:10493 |
Atrophoderma | contraindication | 399979006 | |
Peripheral vascular disease | contraindication | 400047006 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 7.61 | acidic |
pKa2 | 2.03 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Adenosine receptor A3 | GPCR | Ki | 6.28 | DRUG MATRIX | |||||
Epidermal growth factor receptor | Kinase | IC50 | 5.72 | DRUG MATRIX | |||||
Tyrosine-protein kinase Lck | Kinase | IC50 | 5.61 | DRUG MATRIX | |||||
Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.80 | DRUG MATRIX | |||||
Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 5.07 | DRUG MATRIX | |||||
Mitogen-activated protein kinase 3 | Kinase | IC50 | 5.28 | DRUG MATRIX | |||||
Mitogen-activated protein kinase 14 | Kinase | IC50 | 6.44 | DRUG MATRIX | |||||
Mitogen-activated protein kinase 1 | Kinase | IC50 | 6.53 | DRUG MATRIX | |||||
Angiotensin-converting enzyme | Enzyme | IC50 | 6.04 | DRUG MATRIX | |||||
Catechol O-methyltransferase | Enzyme | IC50 | 5.25 | CHEMBL |
ID | Source |
---|---|
4018600 | VUID |
N0000146916 | NUI |
D00581 | KEGG_DRUG |
4018600 | VANDF |
C0012341 | UMLSCUI |
CHEBI:5950 | CHEBI |
CHEMBL86754 | ChEMBL_ID |
DB09115 | DRUGBANK_ID |
3728 | PUBCHEM_CID |
3435 | RXNORM |
2439 | MMSL |
4903 | MMSL |
d01105 | MMSL |
002952 | NDDF |
387355005 | SNOMEDCT_US |
64851009 | SNOMEDCT_US |
D004103 | MESH_DESCRIPTOR_UI |
1613 | INN_ID |
63W7IE88K8 | UNII |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Vytone | HUMAN PRESCRIPTION DRUG LABEL | 2 | 44118-704 | CREAM | 10 mg | TOPICAL | unapproved drug other | 9 sections |
HYDROCORTISONE, IODOQUINOL | HUMAN PRESCRIPTION DRUG LABEL | 2 | 52187-532 | CREAM | 10 mg | TOPICAL | unapproved drug other | 11 sections |
IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES | HUMAN PRESCRIPTION DRUG LABEL | 3 | 52187-545 | GEL | 10 mg | TOPICAL | unapproved drug other | 11 sections |
Hydrocortisone Acetate, Iodoquinol | HUMAN PRESCRIPTION DRUG LABEL | 2 | 52187-551 | CREAM | 10 mg | TOPICAL | unapproved drug other | 9 sections |
Hydrocortisone Acetate, Iodoquinol | HUMAN PRESCRIPTION DRUG LABEL | 2 | 52191-352 | CREAM | 10 mg | TOPICAL | unapproved drug other | 10 sections |
Vytone | HUMAN PRESCRIPTION DRUG LABEL | 2 | 57893-302 | CREAM | 10 mg | TOPICAL | unapproved drug other | 10 sections |
Alcortin | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68040-702 | GEL | 1 g | TOPICAL | unapproved drug other | 2 sections |
Alcortin A | HUMAN PRESCRIPTION DRUG LABEL | 3 | 68040-705 | GEL | 10 mg | TOPICAL | UNAPPROVED OTHER | 17 sections |
Aloquin | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68040-706 | GEL | 12.50 mg | TOPICAL | Unapproved other | 15 sections |
Hydrocortisone Iodoquinol | HUMAN PRESCRIPTION DRUG LABEL | 2 | 69367-286 | CREAM | 10 mg | TOPICAL | UNAPPROVED DRUG OTHER | 18 sections |
Hydrocortisone Iodoquinol | HUMAN PRESCRIPTION DRUG LABEL | 2 | 69367-286 | CREAM | 10 mg | TOPICAL | UNAPPROVED DRUG OTHER | 18 sections |
IODOQUINOL HYDROCORTISONE ACETATE ALOE POLYSACCHARIDES | HUMAN PRESCRIPTION DRUG LABEL | 3 | 72056-020 | GEL | 10 mg | TOPICAL | UNAPPROVED DRUG OTHER | 17 sections |
HYDROCORTISONE IODOQUINOL | HUMAN PRESCRIPTION DRUG LABEL | 2 | 72056-040 | CREAM | 10 mg | TOPICAL | Unapproved drug other | 17 sections |
Corti-Sav | HUMAN PRESCRIPTION DRUG LABEL | 2 | 72336-811 | CREAM | 10 mg | TOPICAL | unapproved drug other | 19 sections |
Corti-Sav | HUMAN PRESCRIPTION DRUG LABEL | 2 | 72336-811 | CREAM | 10 mg | TOPICAL | unapproved drug other | 19 sections |
HYDROCORTISONE 2.5% / IODOQUINOL 1% / KETOCONAZOLE 2% | HUMAN PRESCRIPTION DRUG LABEL | 3 | 72934-2111 | CREAM | 1 g | TOPICAL | unapproved drug other | 4 sections |
Corti-Sav | HUMAN PRESCRIPTION DRUG LABEL | 2 | 80587-101 | CREAM | 10 mg | TOPICAL | unapproved drug other | 3 sections |
SKYNPLEX | HUMAN PRESCRIPTION DRUG LABEL | 2 | 82429-118 | CREAM | 10 mg | TOPICAL | unapproved drug other | 9 sections |
IODOQUINOL HYDROCORTISONE ACETATE ALOE POLYSACCHARIDES | HUMAN PRESCRIPTION DRUG LABEL | 3 | 82429-119 | GEL | 10 mg | TOPICAL | unapproved drug other | 17 sections |